Cite
HARVARD Citation
Masuo, Y. et al. (2020). 6-Hydroxyindole is an endogenous long-lasting OATP1B1 inhibitor elevated in renal failure patients. Drug metabolism and pharmacokinetics. 35 (6), pp. 555-562. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Masuo, Y. et al. (2020). 6-Hydroxyindole is an endogenous long-lasting OATP1B1 inhibitor elevated in renal failure patients. Drug metabolism and pharmacokinetics. 35 (6), pp. 555-562. [Online].